Literature DB >> 11008056

Osmolality of various viscoelastic substances: comparative study.

H B Dick1, A J Augustin, N Pfeiffer.   

Abstract

PURPOSE: To determine the osmolality of various viscoelastic substances.
SETTING: Department of Ophthalmology, Johannes Gutenberg-University, Mainz, and Institute for Medical Device Testing, Memmingen, Germany.
METHODS: The analysis was carried out according to the European Pharmacopoeia by means of a calibrated osmometer using the freezing-point depression method. Each syringe was analyzed as a duplicate analysis.
RESULTS: Mean osmolalities (mOsmol/kg) of the sodium hyaluronate viscoelastic substances were Allervisc 299; Allervisc Plus 307; Amvisc Plus 335; AMO Vitrax 284; Biolon 279; Dispasan 311; Dispasan Plus 314; Healon 295; Healon GV 312; Healon5 322; HYA-Ophtal 376; Microvisc 313; Microvisc Plus 341; Provisc 307; Rayvisc 312; Viscoat 340; Visko 296; Visko Plus 319. Mean osmolarities of the hydroxypropyl methylcellulose viscoeslatic substances were Adatocel 278; HPMC Ophtal L 358; HPMC Ophtal H 360; La Gel 317; OcuCoat 309; Visco Shield 376.
CONCLUSIONS: There were significant differences in osmolality among viscoelastic substances, which may explain the differences in corneal thickness after cataract surgery. A viscoelastic substance with an osmolality of 305 mOsmol/kg or slightly higher is preferable, especially in patients with a compromised corneal endothelium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11008056     DOI: 10.1016/s0886-3350(99)00410-1

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  4 in total

Review 1.  [Phakic intraocular lenses. Current status and limitations].

Authors:  H B Dick; M Tehrani
Journal:  Ophthalmologe       Date:  2004-03       Impact factor: 1.059

2.  Corneal Hydration Control during Ex Vivo Experimentation Using Poloxamers.

Authors:  Keyton Clayson; Thomas Sandwisch; Yanhui Ma; Elias Pavlatos; Xueliang Pan; Jun Liu
Journal:  Curr Eye Res       Date:  2019-09-18       Impact factor: 2.424

3.  Hydroxypropyl methylcellulose 2% for dry eye prevention during phacoemulsification in senile and diabetic patients.

Authors:  Maierhaba Yusufu; Xin Liu; Tianyu Zheng; Fan Fan; Jianjiang Xu; Yi Luo
Journal:  Int Ophthalmol       Date:  2017-07-11       Impact factor: 2.031

4.  Developments in injectable multiphasic biomaterials. The performance of microporous biphasic calcium phosphate granules and hydrogels.

Authors:  G Daculsi; A P Uzel; P Weiss; E Goyenvalle; E Aguado
Journal:  J Mater Sci Mater Med       Date:  2009-11-01       Impact factor: 3.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.